ONCY:NASDAQ
Oncolytics Biotech Inc
0,55 US$
arrow_upward
+0,59%(+0,0032) 1D
9 ოქტ, 12:43:03 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
0,55 US$
High
0,55 US$
Low
0,52 US$
Mkt. cap
72,39 მლნ.
Avg. vol.
1,05 მლნ.
Volume
633,46 ათ.
52-wk high
1,32 US$
52-wk low
0,52 US$
Beta
1,15
Shares outstanding
127,51 მლნ.
No. of employees
29
Open
0,55 US$
High
0,55 US$
Low
0,52 US$
Mkt. cap
72,39 მლნ.
Avg. vol.
1,05 მლნ.
Volume
633,46 ათ.
52-wk high
1,32 US$
52-wk low
0,52 US$
Beta
1,15
Shares outstanding
127,51 მლნ.
No. of employees
29
News stories
From web sources and news partners
Yahoo Finance
·
54 წუთის წინ
Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up
The Manila Times
·
1 საათის წინ
IT Tech Packaging, Inc. Announces NYSE Regulation Acceptance of Extension Request; Listing Continued Pursuant to Extension Through April 15, 2027
MarketBeat
·
15 წუთის წინ
Latigo Biotherapeutics (NASDAQ:LTGO) Shares Climb 6.2% - Time to Buy?
Nasdaq
·
3 საათის წინ
WISeSat.Space Holdings Corp. Rings the Opening Bell
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc